Antibody response six months after the booster dose of Pfizer in
previous recipients of CoronaVac
- Maria Francilene Souza Silva,
- Ana Carolina Matias Dinelly Pinto,
- Fátima de Cássia Evangelista de Oliveira,
- Ludmilla Freire Caetano,
- Fernanda Montenegro de Carvalho Araújo,
- Marcela Helena Gambim Fonseca
Ana Carolina Matias Dinelly Pinto
Fundação Oswaldo Cruz Eusébio Brazil
Author ProfileFátima de Cássia Evangelista de Oliveira
Fundação Oswaldo Cruz Eusébio Brazil
Author ProfileLudmilla Freire Caetano
Fundação Oswaldo Cruz Eusébio Brazil
Author ProfileFernanda Montenegro de Carvalho Araújo
Fundação Oswaldo Cruz Eusébio Brazil
Author ProfileMarcela Helena Gambim Fonseca
Fundação Oswaldo Cruz Eusébio Brazil
Author ProfileAbstract
We evaluated antibody levels after six months of the booster dose with
BNT162B2 in previous recipients of CoronaVac and whether a subsequent
SARS-COV-2 infection enhances the antibody response. The booster shot
induced IgM and IgG antibodies against Spike protein. Infection after
vaccination increased antibodies against protein N.